2018

The I.M. Rosenzweig Junior Investigator Award Winners​

The I.M. Rosenzweig Junior Investigator Award was established to encourage researchers to maintain and enhance their interest in PF research during the early stages of their academic career. 

Nabeel Hamzeh, MD

Apr 20, 2021, 12:48 PM
Title : Nabeel Hamzeh, MD
First Name : Nabeel
Middle Name :
Last Name : Hamzeh, MD
Position :
University : The University of Iowa
Proposal Title : CD4 T-cell immunephenotype in hypersenstivity pneumonitis
Proposal Funder : Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Hamzeh is an Associate Professor at the University of Iowa in the division of Pulmonary, Critical Care and Occupational medicine. He is the director of the interstitial lung disease program. His clinical and research interests focus on granulomatous lung diseases, specifically sarcoidosis and hypersensitivity pneumonitis. His research explores the pathophysiology of sarcoidosis with the goal of introducing novel diagnostic, prognostic and therapeutic agents to the clinic. His work focuses on the:
i) role of genetics and epigenetics in sarcoidosis disease activity
ii) diagnosis and management of cardiac sarcoidosis
iii) role of humoral immunity in sarcoidosis pathogenesis and
iv) the immune response in hypersensitivity pneumonitis.
Load more comments
Comment by from

The Albert Rose Established Investigator Award Winners

Created to allow established investigators to explore novel, innovative areas of research, the Albert Rose Established Investigator Award provides critical support to the development of new projects, and enables the investigator to pursue additional funding through the National Institutes of Health or other agencies. Two $50,000 grants are awarded per annual cycle, disbursed over a two-year period.

Nabeel Hamzeh, MD

Apr 20, 2021, 12:48 PM
Title : Nabeel Hamzeh, MD
First Name : Nabeel
Middle Name :
Last Name : Hamzeh, MD
Position :
University : The University of Iowa
Proposal Title : CD4 T-cell immunephenotype in hypersenstivity pneumonitis
Proposal Funder : Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Hamzeh is an Associate Professor at the University of Iowa in the division of Pulmonary, Critical Care and Occupational medicine. He is the director of the interstitial lung disease program. His clinical and research interests focus on granulomatous lung diseases, specifically sarcoidosis and hypersensitivity pneumonitis. His research explores the pathophysiology of sarcoidosis with the goal of introducing novel diagnostic, prognostic and therapeutic agents to the clinic. His work focuses on the:
i) role of genetics and epigenetics in sarcoidosis disease activity
ii) diagnosis and management of cardiac sarcoidosis
iii) role of humoral immunity in sarcoidosis pathogenesis and
iv) the immune response in hypersensitivity pneumonitis.
Load more comments
Comment by from